Richard Kuntz - May 30, 2023 Form 3 Insider Report for DiaMedica Therapeutics Inc. (DMAC)

Role
Director
Signature
/s/ Amy Culbert, attorney-in-fact
Stock symbol
DMAC
Transactions as of
May 30, 2023
Transactions value $
$0
Form type
3
Date filed
5/30/2023, 04:21 PM
Previous filing
May 16, 2023
Next filing
Jul 5, 2023

No securities are beneficially owned.

Remarks:

No securities are beneficially owned Exhibit List - Exhibit No. 24 - Power of Attorney